Mitem Pharma

Develops and commercializes essential and niche medicines for patients with serious conditions

Massy, FranceFounded 1998mitempharma.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-08

About Mitem Pharma

Mitem Pharma is a French pharmaceutical laboratory focused on medicines of major therapeutic interest. It develops, acquires, commercializes and revalues essential, niche and previously neglected treatments, and works to secure their supply.

The company identifies treatments with doctors and patient associations, then relaunches, improves or develops medicines to support patient access to care. It is based in Massy, France, and was founded in 1998.

Product: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest.

Public tenders won

1 tender won since 1 Jan 2024 from 1 public buyer in France. From EU award notices (TED) that name Mitem Pharma by its registry number.

  • 16 May 2025 GCS GRAPS GRAND EST · Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est notice

Open tenders like these →

Jobs at Mitem Pharma

No open positions listed right now.

More biotech & pharma companies

  • Molsid

    Fluorogenic probes and rapid tests detecting beta-lactamase and bacterial growth
    Lyon, FranceBiotech & pharmaFounded 2018
    New on Evolc
  • MSD France

    Develops medicines and vaccines for patients and public health needs in France and worldwide
    Puteaux, FranceBiotech & pharmaFounded 1998
    New on Evolc
  • Mycea

    Develops fungal-extract crop protection candidates for agricultural and biocontrol partners
    Montpellier, FranceBiotech & pharmaFounded 2018
    New on Evolc
  • Naemos

    Plant-based cosmetic active ingredients from indoor-farmed microgreens and eco-extraction, sold to cosmetic brands
    Marseille, FranceBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Nanobiotix

    Physics-based nanotherapeutics for cancer, with lead candidate NBTXR3 in clinical development with Janssen
    Paris, FranceBiotech & pharmaFounded 2003
    New on Evolc
  • Nanoreviv

    Develops localized antibiotic formulations for pharmaceutical partners and patients with local infections
    Loos, FranceBiotech & pharmaFounded 2023
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Backend

  • PHPHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • ApacheHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.